Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use(COVID-19 Version)
ReportPage
Report ID
688543
Published Date
02-Sep
No of Report Page
97
Report Category
Life Sciences
Editor's Rating
US $6,000.00
US $6,000.00
US $3,000.00

  • Report Details 
    Summary
    

    Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
    

    The report forecast global Glucagon Like Peptide-1 (GLP-1) Agonists market to grow to reach
    More...
  • Table Of Content 
    Table of Contents
    
Part 1 Market Overview
    
    1.1 Market Definition
    
    1.2 Market Development
    
        1.2.1 Current Situation
    
        1.2.2 Aspects of COVID-19 Impact
    
    1.3 By Type
    
                Table Type of Glucagon Like Peptide-1 (GLP-1) Agonists
    
                Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type in 2019
    
    1.4 By Application
    
                Table A
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -